title: The optimal starting time of postoperative intraperitoneal mitomycin-C therapy with preserved intestinal wound healing.
abstract: BACKGROUND
  There is controversy about the effect of the timing of intraperitoneal administration of chemotherapeutic agents on the healing of intestinal anastomosis. We have investigated the effect on intestinal wound healing of mitomycin-C administered at different times post-operatively.
  
  
  METHODS
  Eighty-four Wistar-Albino female rats underwent ileal resection and end-to-end anastomosis. The rats were randomly selected for intraperitoneal administration of mitomycin-C or saline as follows: mitomycin-C group (n = 65), 2 mg/kg mitomycin-C; control group (n = 13), 10 ml saline. The former was sub-divided into 5 equal groups (A 1-5) and mitomycin-C was administered postoperatively as follows: day 0 (A1), day 3 (A2), day 5 (A3), day 7 (A4) and day 10 (A5). All the rats were sacrificed on the 14th postoperative day and anastomotic bursting pressures and tissue hydroxyproline levels were determined.
  
  
  RESULTS
  Five of the animals died postoperatively: 2 (15.4%) in group A1, 2 (15.4%) in group A2 and 1(7.7%) in group A3. Non-lethal anastomotic leakage was observed in a further five animals: 1 in group A1, 2 in group A2, 1 in group A5 and 1 in the control group. Groups A1 and A2 had significantly lower anastomotic bursting pressures than the other groups (P was <0.05 for each comparison). The anastomotic bursting pressures of group A3, A4 and A5 were comparable with those of the controls (P was >0.05 for each comparison). Tissue hydroxyproline levels in group A1 and A2 were significantly lower than in the controls (P values were <0.05 for each comparison) or the other mitomycin-C sub-groups (P was <0.05 for each comparison).
  
  
  CONCLUSIONS
  Intraperitoneal chemotherapy impairs intestinal wound healing when applied before the 5th postoperative day. Additional therapeutic approaches are needed to prevent this potentially lethal side effect of early intraperitoneal mitomycin-C administration.
authors.affiliation: Department of Surgery, Harran University, Sanliurfa, Turkey. aliuzunkoy@yahoo.com
authors.forename: Ali
authors.initials: A
authors.lastname: Uzunkoy
authors.forename: Cengiz
authors.initials: C
authors.lastname: Bolukbas
authors.forename: Mehmet
authors.initials: M
authors.lastname: Horoz
authors.forename: Fusun F
authors.initials: FF
authors.lastname: Bolukbas
authors.forename: Abdurrahim
authors.initials: A
authors.lastname: Kocyigit
mesh_terms: D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005260:Female; D007274:Injections, Intraperitoneal; D016685:Mitomycin / Q000008:administration & dosage*; D011182:Postoperative Care / Q000379:methods*; D011897:Random Allocation; D051381:Rats; D017208:Rats, Wistar; D014945:Wound Healing / Q000187:drug effects*
chemical_list: D000903:Antibiotics, Antineoplastic; D016685:Mitomycin